Identification of β-Lactams Active against <i>Mycobacterium tuberculosis</i> by a Consortium of Pharmaceutical Companies and Academic Institutions.
Journal Information
Full Title: ACS Infect Dis
Abbreviation: ACS Infect Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Anti-Infective Agents
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"The authors declare no competing financial interest."
"This work was supported by the TB Drug Accelerator Program of the Bill & Melinda Gates Foundation, the Abby and Howard P. Milstein Program in Chemical Biology and Translational Medicine, the Tri-Institutional TB Research Unit funded by NIAID, NIH (U19 AI111143), grants OPP1024038 and OPP1174780 from the Bill & Melinda Gates Foundation, and the Intramural Research Program of the NIAID, NIH. The WCM Department of Microbiology and Immunology is supported by the William Randolph Hearst Trust."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025